hematologic toxicity

Related by string. Hematologic toxicity * Hematologic : hematologic toxicity correlated . hematologic malignancies . Hematologic Malignancies . hematologic toxicities . common hematologic malignancy . hematologic adverse reactions / Toxicity . TOXICITY : mitochondrial toxicity . morphine toxicity . systemic toxicity . renal toxicity . limiting toxicity DLT . dermatologic toxicity * *

Related by context. Frequent words. (Click for all words.) 77 laboratory abnormalities 75 myelosuppression 74 febrile neutropenia 74 lymphopenia 73 thromboembolic events 73 leukopenia 72 Neutropenia 72 mg kg dose 71 limiting toxicity 71 hypomagnesemia 71 dose limiting toxicities 71 hepatotoxicity 71 events AEs 71 hypercalcemia 70 hypocalcemia 69 toxicities 69 cerebrovascular events 69 thrombocytopenia 69 cytogenetic response 69 hyperkalemia 68 discontinuations due 68 adrenal insufficiency 68 neutropenia 68 virologic failure 68 cytotoxic chemotherapy 67 hypokalemia 67 renal insufficiency 67 virologic response 67 infusion reactions 67 tumor lysis syndrome 66 cardiac toxicity 66 Adverse events 66 lactic acidosis 66 thromboembolism 66 hypersensitivity reactions 66 CMV infection 66 mucositis 66 renal dysfunction 66 fibrinolysis 66 events SAEs 66 plus methotrexate 65 PROMACTA 65 amenorrhea 65 EBRT 65 hypersensitivity reaction 65 proteinuria 65 enalapril 65 VUR 65 esophagitis 65 angiotensin converting enzyme inhibitors 65 thrombotic events 65 FOLFIRI 65 azacitidine 65 DMARDs 65 Navelbine 65 NRTI 65 neuropsychiatric symptoms 65 neoplasm 65 Fludara 64 endophthalmitis 64 complete remissions 64 T2DM 64 angioedema 64 interferon alfa 64 serum sodium 64 mitoxantrone 64 pleural effusion 64 immunosuppressive agents 64 severe renal impairment 64 ketoconazole 64 decitabine 64 octreotide 64 discontinuations 64 AEs 64 NNRTIs 64 hypoxemia 64 anticholinergics 64 TORISEL 64 lymph node involvement 64 inflammatory lesions 64 treatment emergent adverse 64 neoplasms 63 stomatitis 63 chemoradiotherapy 63 neoadjuvant therapy 63 relapsing remitting 63 DMARD 63 allogeneic stem cell 63 grade gliomas 63 tumor recurrence 63 patients receiving ERBITUX 63 pneumonitis 63 vinorelbine 63 hepatic impairment 63 serum calcium 63 composite endpoint 63 mg BID 63 grade glioma 63 adefovir 63 systemic absorption 63 P = .#

Back to home page